Valneva SE (VALN) Total Current Liabilities (2020 - 2026)

Valneva SE (VALN) posted quarterly Total Current Liabilities of $107.2 million for Q1 2026, down 11.28% year-on-year from $120.9 million in Q1 2025, and up 0.95% on a QoQ basis from $106.2 million in Q4 2025.

Valneva SE (VALN) Total Current Liabilities (2020 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Total Current Liabilities for 7 consecutive years, with $107.2 million the latest figure, recorded in Q1 2026.

  • Quarterly Total Current Liabilities fell 11.28% year-over-year to $107.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $107.2 million (down 11.28% YoY) and the FY2025 annual result came in at $106.2 million, down 18.54% from the prior year.
  • Total Current Liabilities grew to $107.2 million in Q1 2026 per VALN's latest filing, from $106.2 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for VALN reached as high as $496.3 million in Q2 2022 and fell as low as $106.2 million in Q4 2025.
  • A 5-year average of $223.9 million and a median of $171.2 million in 2025 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2024 — Total Current Liabilities tumbled 57.48% — and 2025, when it jumped 37.86%.
  • Year by year, Total Current Liabilities stood at $315.7 million in 2022, then sank by 42.73% to $180.8 million in 2023, then decreased by 27.87% to $130.4 million in 2024, then decreased by 18.54% to $106.2 million in 2025, then rose by 0.95% to $107.2 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $107.2 million, $106.2 million, and $171.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn 107.22 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 107.22 Mn
Dec 31, 2025 106.21 Mn
Sep 30, 2025 171.24 Mn
Jun 30, 2025 143.00 Mn
Mar 31, 2025 120.85 Mn
Dec 31, 2024 130.39 Mn
Sep 30, 2024 124.21 Mn
Jun 30, 2024 116.63 Mn
Mar 31, 2024 132.10 Mn
Dec 31, 2023 180.78 Mn
Sep 30, 2023 248.25 Mn
Jun 30, 2023 274.30 Mn
Mar 31, 2023 299.58 Mn
Dec 31, 2022 315.66 Mn
Sep 30, 2022 425.84 Mn
Jun 30, 2022 496.29 Mn
Mar 31, 2022 413.37 Mn
Dec 31, 2021 419.88 Mn
Dec 31, 2020 200.13 Mn